Data for ST000779   

(Analysis AN001232): Average values per metabolite and experimental factor (Units:Peak area normalized)

Metabolite structureAll dataF1F2F3F4F5F6F7
CerP 40:1; [M-H]-@7.70
7.69 8.21 7.84 8.05 7.78 8.15 7.93
CL 68:4; [M-2H](2-)@6.71
8.74 8.88 7.51 6.98 8.81 7.85 8.06
CL 70:3; [M-2H](2-)@5.63
7.91 6.77 6.85 6.44 6.91 5.54 7.21
CL 70:5; [M-2H](2-)@6.00
9.82 10.20 8.59 8.60 9.18 9.47 9.62
CL 72:5; [M-2H](2-)@6.24
8.55 8.85 8.78 8.48 8.50 8.16 8.66
CL 74:1; [M-2H](2-)@5.98
10.40 10.27 10.07 9.56 10.25 10.49 10.49
CL 74:1; [M-2H](2-)@6.76
11.62 10.98 11.25 11.17 10.79 11.09 10.39
CL 74:3; [M-2H](2-)@6.22
11.62 11.35 11.24 10.90 11.14 11.31 10.90
CL 74:5; [M-2H](2-)@5.74
9.56 10.05 9.50 9.71 8.90 9.93 8.64
CL 74:7; [M-2H](2-)@6.06
12.41 12.68 11.76 11.70 12.20 11.82 12.09
CL 74:9; [M-2H](2-)@6.00
9.99 10.08 8.65 8.75 9.67 8.91 9.32
CL 76:1; [M-2H](2-)@6.68
8.47 8.12 8.38 8.11 8.55 8.51 8.62
CL 76:3; [M-2H](2-)@6.23
8.98 8.76 9.00 8.81 8.07 8.72 7.87
CL 76:5; [M-2H](2-)@6.89
9.16 9.28 8.90 9.21 8.83 9.09 8.96
CL 78:13; [M-2H](2-)@5.84
8.91 9.34 8.21 7.37 8.60 8.92 9.18
CL 78:1; [M-2H](2-)@7.29
10.59 10.38 9.50 8.82 9.65 10.00 10.49
CL 78:3; [M-2H](2-)@6.76
11.59 11.91 11.41 11.30 11.54 11.65 12.04
CL 78:4; [M-2H](2-)@6.45
9.26 9.72 9.66 9.19 9.68 9.51 9.37
CL 78:5; [M-2H](2-)@6.42
10.50 10.22 10.07 9.89 10.54 10.44 10.17
CL 78:6; [M-2H](2-)@5.95
10.90 10.54 10.15 10.37 10.71 10.84 10.80
CL 78:7; [M-2H](2-)@5.85
11.60 11.85 9.82 8.18 11.30 11.77 12.03
CL 78:7; [M-2H](2-)@6.22
11.78 11.85 10.74 10.62 11.30 11.77 12.03
CL 78:9; [M-2H](2-)@5.74
10.38 10.25 9.70 9.79 9.09 10.17 9.67
CL 80:13; [M-2H](2-)@6.05
9.16 9.89 7.91 8.02 8.66 9.15 8.88
CL 80:3; [M-2H](2-)@6.89
8.00 9.38 8.65 9.37 9.35 9.05 8.76
CL 80:9; [M-2H](2-)@6.01
9.01 8.97 8.04 7.97 9.29 9.03 8.68
CL 82:15; [M-2H](2-)@5.98
11.43 10.85 10.17 10.16 9.99 10.99 10.97
lysoPE 16:0; [M-H]-@1.65
12.98 12.93 12.45 12.23 12.54 12.85 12.83
lysoPE 16:1; [M-H]-@1.22
9.13 9.05 8.28 8.46 8.67 8.99 8.95
lysoPE 18:0; [M-H]-@2.42
12.99 12.60 12.10 11.79 12.43 12.79 12.92
lysoPE 18:1; [M-H]-@1.80
12.76 13.02 12.16 11.98 12.40 12.39 12.79
lysoPE 18:2; [M-H]-@1.31
13.10 13.20 12.78 13.04 12.54 13.00 12.66
lysoPE 20:3; [M-H]-@1.60
11.06 11.19 10.23 10.24 10.81 10.93 11.28
lysoPE 20:4; [M-H]-@1.32
14.22 14.01 13.55 13.46 14.10 14.05 14.18
lysoPE 22:4; [M-H]-@1.79
10.69 10.89 9.85 9.32 9.44 10.34 11.03
lysoPE 22:5; [M-H]-@1.60
12.92 12.89 12.29 12.07 12.34 12.49 12.79
lysoPE 22:6; [M-H]-@1.28
13.85 13.54 12.80 12.22 13.56 13.89 13.94
PA 26:3; [M-H]-@1.50
12.04 12.35 11.93 11.82 12.19 11.84 12.42
PA 28:4; [M-H]-@1.82
11.69 11.89 11.18 10.59 11.49 11.20 11.66
PA 34:0; [M-H]-@7.02
9.97 9.39 10.02 10.13 10.46 9.99 10.59
PA 34:0; [M-H]-@7.68
8.67 8.40 8.70 8.86 8.54 8.99 8.45
PA 36:3; [M-H]-@6.23
9.58 9.62 9.66 9.51 8.93 9.91 8.98
PC 30:0; [M-Ac-H]-@5.94
9.63 9.28 8.93 9.03 9.27 9.48 9.77
PC 31:1; [M-Ac-H]-@6.46
9.58 10.04 9.77 10.14 10.11 10.32 9.64
PC 32:0; [M-Ac-H]-@6.59
11.28 10.88 11.12 11.26 10.98 11.37 11.01
PC 32:1; [M-Ac-H]-@6.07
11.17 10.86 10.44 10.37 10.67 10.71 10.78
PC 32:2; [M-Ac-H]-@5.60
10.00 9.74 9.44 9.33 9.80 9.71 9.64
PC 33:1; [M-Ac-H]-@6.41
10.64 10.63 10.06 9.44 10.78 10.15 10.20
PC 33:2; [M-Ac-H]-@5.95
10.88 10.81 10.60 10.67 10.57 11.04 10.12
PC 34:0; [M-Ac-H]-@7.21
11.98 11.98 11.97 11.98 11.98 11.98 11.97
PC 34:1; [M-Ac-H]-@6.67
13.88 13.57 13.13 12.92 13.71 13.43 13.55
PC 34:2; [M-Ac-H]-@6.23
14.46 14.17 13.90 13.77 13.83 14.38 13.85
PC 34:3; [M-Ac-H]-@5.78
11.89 11.80 11.26 10.78 11.06 11.33 11.55
PC 34:4; [M-Ac-H]-@5.54
9.59 9.57 8.55 7.90 9.31 9.20 9.45
PC 35:1; [M-Ac-H]-@7.01
9.37 9.65 9.44 9.80 9.39 9.94 9.31
PC 35:2; [M-Ac-H]-@6.53
10.91 10.74 10.59 11.31 11.20 10.65 10.81
PC 35:3; [M-Ac-H]-@6.10
9.30 9.11 9.37 9.66 9.19 9.95 9.16
PC 35:4; [M-Ac-H]-@5.91
11.10 10.93 10.54 10.58 11.22 11.20 11.13
PC 36:0; [M-Ac-H]-@7.79
11.01 10.85 9.76 9.19 10.59 10.68 11.08
PC 36:1; [M-Ac-H]-@7.30
12.95 12.54 12.06 11.44 12.54 12.71 12.84
PC 36:2; [M-Ac-H]-@6.87
14.37 14.18 13.98 13.80 14.20 14.30 14.13
PC 36:3; [M-Ac-H]-@6.41
13.36 13.10 12.94 13.13 13.03 13.55 12.72
PC 36:4; [M-Ac-H]-@6.08
14.38 14.09 13.53 13.38 14.29 14.31 14.17
PC 36:5; [M-Ac-H]-@5.69
11.10 11.15 10.41 10.03 10.89 10.94 10.96
PC 36:6; [M-Ac-H]-@5.40
8.81 8.60 8.41 7.30 9.02 9.30 9.02
PC 37:2; [M-Ac-H]-@7.21
9.22 9.25 9.33 9.53 9.33 9.30 9.26
PC 37:4; [M-Ac-H]-@6.54
11.15 11.07 10.71 10.86 11.65 11.30 11.43
PC 38:2; [M-Ac-H]-@7.45
10.33 10.23 10.16 10.00 9.07 10.62 9.89
PC 38:3; [M-Ac-H]-@7.08
13.19 12.78 12.40 12.44 13.04 13.35 12.78
PC 38:4; [M-Ac-H]-@6.74
14.72 14.34 13.69 13.52 14.81 14.51 14.83
PC 38:5; [M-Ac-H]-@6.41
13.22 13.16 12.45 12.03 12.86 12.98 12.99
PC 38:6; [M-Ac-H]-@5.98
13.22 12.99 12.28 12.31 12.77 13.26 13.07
PC 38:7; [M-Ac-H]-@5.59
11.34 11.45 10.75 9.96 10.61 10.27 10.41
PC 39:4; [M-Ac-H]-@7.18
8.75 8.81 8.81 8.84 9.18 8.28 8.58
PC 39:6; [M-Ac-H]-@6.75
9.82 9.71 8.82 7.57 9.96 9.27 9.70
PC 40:4; [M-Ac-H]-@7.30
10.64 10.28 9.99 9.80 10.33 10.27 10.71
PC 40:5; [M-Ac-H]-@7.05
12.48 12.48 11.50 11.21 12.15 12.09 12.94
PC 40:6; [M-Ac-H]-@6.68
12.87 12.61 11.46 11.22 12.62 12.67 12.73
PC 40:7; [M-Ac-H]-@6.22
11.53 11.47 10.62 10.05 11.17 11.28 11.56
PC 40:8; [M-Ac-H]-@5.77
11.54 11.23 10.41 9.26 10.81 11.44 10.90
PC 42:10; [M-Ac-H]-@5.70
9.97 9.98 8.85 7.78 9.79 9.64 9.69
PC 42:9; [M-Ac-H]-@6.11
9.23 9.78 9.25 9.07 9.64 9.61 9.17
PE 32:0; [M-H]-@6.75
9.66 9.07 8.87 9.09 8.29 9.33 9.28
PE 33:2; [M-H]-@6.05
6.92 7.50 7.25 8.16 6.62 7.97 7.37
PE 34:0; [M-H]-@6.58
9.33 9.48 9.66 9.94 8.84 9.05 9.20
PE 34:0; [M-H]-@7.23
13.92 13.91 13.92 13.92 13.92 13.93 13.91
PE 34:1; [M-H]-@6.82
11.79 11.93 11.42 11.67 11.16 11.45 11.04
PE 34:2; [M-H]-@4.87
7.99 7.73 7.69 7.28 7.45 8.03 7.53
PE 34:2; [M-H]-@6.40
11.94 11.87 11.81 11.76 11.37 11.46 11.06
PE 34:3; [M-H]-@5.96
10.08 10.44 8.93 9.38 8.96 9.49 9.78
PE 35:1; [M-H]-@7.10
7.02 7.09 7.29 7.58 7.00 7.84 7.19
PE 35:2; [M-H]-@6.68
9.86 10.03 9.48 9.47 8.95 9.65 8.92
PE 36:0; [M-H]-@7.19
9.53 9.98 9.43 10.05 9.26 10.01 9.58
PE 36:1; [M-H]-@6.68
11.09 10.68 10.65 10.30 10.99 10.56 10.57
PE 36:1; [M-H]-@7.40
10.22 10.04 10.09 9.43 9.91 9.62 9.41
PE 36:2; [M-H]-@6.25
11.78 11.55 11.35 11.31 11.22 11.48 11.22
PE 36:2; [M-H]-@6.93
12.76 12.71 12.68 12.59 12.41 12.40 11.82
PE 36:3; [M-H]-@6.50
12.36 12.33 12.18 12.29 11.84 11.98 11.63
PE 36:4; [M-H]-@6.24
12.69 12.94 11.98 11.88 12.41 12.05 12.27
PE 36:5; [M-H]-@5.90
9.87 10.26 8.93 8.43 9.34 9.11 9.65
PE 37:4; [M-H]-@6.65
9.83 9.90 9.42 9.31 9.07 9.36 9.06
PE 37:5; [M-H]-@6.16
10.02 10.19 9.90 9.58 10.67 9.98 10.07
PE 38:1; [M-H]-@7.31
10.40 10.02 9.63 8.97 9.56 9.37 10.05
PE 38:2; [M-H]-@6.84
12.02 12.24 11.61 11.35 11.50 11.80 12.32
PE 38:3; [M-H]-@6.42
10.74 10.25 10.16 10.27 10.02 10.87 10.77
PE 38:3; [M-H]-@7.18
11.54 11.53 11.01 10.66 11.01 11.33 11.43
PE 38:4; [M-H]-@6.18
11.54 11.46 11.10 11.24 11.19 11.86 11.26
PE 38:4; [M-H]-@6.94
13.68 13.59 13.11 13.05 13.46 13.45 13.43
PE 38:5; [M-H]-@4.99
8.73 8.36 7.95 8.01 8.41 8.44 8.70
PE 38:5; [M-H]-@5.75
10.05 10.15 9.54 9.29 9.18 9.56 9.40
PE 38:5; [M-H]-@6.50
13.56 13.50 12.78 12.68 13.22 13.19 13.15
PE 38:6; [M-H]-@6.11
14.05 13.92 13.33 13.11 13.66 13.51 13.90
PE 38:7; [M-H]-@5.83
9.28 9.68 8.34 7.43 8.68 8.93 9.21
PE 39:2; [M-H]-@6.86
9.09 9.22 8.87 9.35 9.27 9.14 9.05
PE 40:4; [M-H]-@6.84
11.97 11.50 11.25 11.19 12.11 11.69 12.29
PE 40:4; [M-H]-@7.37
8.13 8.07 8.68 9.36 8.61 8.72 8.87
PE 40:5; [M-H]-@6.33
9.93 9.95 9.48 9.47 10.04 10.25 9.50
PE 40:5; [M-H]-@7.06
11.33 11.13 10.86 11.13 10.84 11.01 11.20
PE 40:6; [M-H]-@6.10
10.85 10.63 9.86 9.65 10.31 10.90 10.61
PE 40:7; [M-H]-@6.32
13.16 13.03 12.39 12.29 12.90 12.72 13.02
PE 40:8; [M-H]-@5.96
11.80 11.78 11.14 10.92 11.40 11.60 11.65
PE 42:10; [M-H]-@5.81
11.73 11.23 10.74 10.30 10.23 11.16 11.32
PE 42:9; [M-H]-@6.22
9.49 9.41 8.21 8.30 8.44 9.40 9.26
PG 32:0; [M-H]-@5.76
9.85 10.23 9.76 10.04 9.06 9.70 9.57
PG 34:0; [M-H]-@6.27
9.70 9.69 8.87 8.61 9.09 9.34 9.47
PG 34:1; [M-H]-@5.84
9.91 9.51 9.64 10.09 9.78 10.10 9.54
PG 34:2; [M-H]-@5.37
9.40 9.23 9.30 9.32 9.09 9.52 9.47
PG 35:3; [M-H]-@6.28
7.98 7.97 8.37 8.28 8.25 8.71 8.11
PG 36:0; [M-H]-@6.87
11.51 11.33 9.40 10.87 10.91 10.20 10.84
PG 36:1; [M-H]-@6.45
9.93 9.86 8.99 8.97 9.67 9.78 9.78
PG 36:2; [M-H]-@5.91
12.27 12.05 11.52 11.57 12.37 12.22 12.14
PG 36:3; [M-H]-@5.55
9.01 9.00 8.43 8.96 9.24 9.22 9.48
PG 36:4; [M-H]-@5.43
8.46 8.23 8.05 7.69 8.09 8.27 8.23
PG 38:4; [M-H]-@6.05
11.44 11.12 10.15 10.44 11.83 10.91 11.55
PG 38:5; [M-H]-@5.26
8.08 7.70 7.27 7.74 7.98 8.29 7.67
PI 34:2; [M-H]-@5.22
9.13 8.59 9.08 9.28 8.40 9.04 7.98
PI 36:2; [M-H]-@5.84
10.81 10.55 10.80 10.68 10.21 11.02 10.16
PI 36:3; [M-H]-@5.37
9.12 9.03 9.30 9.18 8.61 9.31 8.70
PI 36:4; [M-H]-@5.21
10.72 10.74 10.41 10.30 9.75 10.77 10.22
PI 37:4; [M-H]-@5.54
10.65 10.65 10.64 10.66 10.64 10.68 10.65
PI 38:3; [M-H]-@6.06
12.46 12.25 11.85 10.99 11.46 12.25 12.11
PI 38:4; [M-H]-@5.82
14.37 13.97 13.63 12.83 13.58 14.17 13.79
PI 38:5; [M-H]-@5.35
10.43 10.54 10.02 9.70 9.43 10.17 9.73
PI 40:3; [M-H]-@5.27
10.16 10.54 10.51 10.22 8.91 9.66 10.10
PI 40:5; [M-H]-@5.02
7.87 8.42 7.94 6.96 5.79 8.36 8.74
PI 40:6; [M-H]-@5.79
9.58 9.12 9.01 8.32 9.44 9.99 9.57
plasmenyl-PE 34:0; [M-H]-@7.17
9.32 9.39 8.77 8.43 8.75 9.58 8.86
plasmenyl-PE 34:1; [M-H]-@7.13
10.20 9.86 9.84 9.84 10.07 10.02 10.02
plasmenyl-PE 34:2; [M-H]-@6.69
11.58 11.38 11.48 11.46 11.35 11.49 11.15
plasmenyl-PE 36:1; [M-H]-@7.69
10.31 9.35 10.05 9.88 9.43 9.79 9.37
plasmenyl-PE 36:2; [M-H]-@7.30
11.67 11.32 10.98 10.84 11.22 11.38 11.40
plasmenyl-PE 36:4; [M-H]-@6.63
13.38 12.95 12.62 12.31 12.96 13.23 13.03
plasmenyl-PE 36:5; [M-H]-@6.27
10.07 10.19 8.97 8.91 9.45 9.61 10.17
plasmenyl-PE 38:1; [M-H]-@8.18
10.45 9.95 9.97 9.86 9.98 10.25 9.90
plasmenyl-PE 38:2; [M-H]-@7.84
9.72 9.69 9.43 9.34 9.47 9.76 9.50
plasmenyl-PE 38:3; [M-H]-@7.48
11.93 11.54 11.28 10.87 11.37 11.90 11.73
plasmenyl-PE 38:4; [M-H]-@7.20
12.69 12.08 12.13 11.38 12.29 12.63 12.48
plasmenyl-PE 38:5; [M-H]-@6.90
13.06 12.94 12.78 12.69 13.00 13.18 13.14
plasmenyl-PE 38:6; [M-H]-@6.51
13.27 12.86 12.38 12.16 12.77 13.25 12.82
plasmenyl-PE 40:4; [M-H]-@7.70
11.67 11.23 11.07 10.88 11.23 11.66 11.53
plasmenyl-PE 40:5; [M-H]-@7.40
12.32 11.97 11.46 11.06 11.59 12.26 11.98
plasmenyl-PE 40:6; [M-H]-@7.07
12.71 12.23 11.74 11.82 12.44 12.68 12.43
plasmenyl-PE 42:4; [M-H]-@8.11
9.24 7.57 9.24 9.21 9.46 9.83 9.55
plasmenyl-PE 42:5; [M-H]-@7.81
11.67 11.18 10.81 10.49 11.16 11.74 11.25
plasmenyl-PE 42:6; [M-H]-@7.70
11.42 11.16 10.52 10.13 10.81 11.54 11.34
PS 38:4; [M-H]-@5.96
9.23 8.91 8.46 8.48 8.52 8.90 8.71
PS 40:8; [M-H]-@4.90
7.50 8.51 8.13 8.76 7.44 9.01 8.06

Factors:

F1Age (months):10.1 | Diet:Mediterranean
F2Age (months):10.3 | Diet:Western
F3Age (months):10.4 | Diet:Control
F4Age (months):10.4 | Diet:Mediterranean
F5Age (months):10.4 | Diet:Western
F6Age (months):10.5 | Diet:Control
F7Age (months):10.5 | Diet:Western
  logo